Dechra is highlighting two new published case reports in which horses vaccinated with its strangles vaccine, Strangvac, did not develop clinical strangles during outbreaks on two Swedish yards.

In the first report¹, which concerned an outbreak on a busy…

Dechra Veterinary Products is celebrating sales of 100 million sachets of Equipalazone® Powder with a campaign in which customers will get a special deal, and the chance to enter a draw for a VIP, 3-day trip to Badminton 2008.

Dechra Veterinary Products, manufacturer and distributor of Equipalazone®, has launched a new information leaflet to support the Equine Passport scheme.

Since 2005, when equine passports became mandatory, 958,000 have been issued. The passport…

Dechra Veterinary Products is offering vets free Identichips® worth £100 when they order Equipalazone® Powder 100s.

The European Union (EU) has now approved regulations that any equine foal born after July 1 2009 should be micro-chipped…

Dechra Veterinary Products, manufacturer and distributor of Equipalazone^®, has launched a new website with up-to-date advice and guidance on the subject of equine pain management for horse owners: http://www.equinepainmatters.com/

Dechra says the…

Dechra Veterinary Products has picked up a major award at the 2011 Veterinary Marketing Awards for a calendar called 'The Horse in History'.

The calendar, designed to promote all of Dechra's equine products but particularly Equipalazone, also won…

Dechra Veterinary Products has launched Myorelax, a guaifenesin 100 mg/ml solution for infusion for horses which, the company says, relaxes skeletal muscles within minutes.

Dechra's Equine Brand Manager Emma Jennings said: "Myorelax is indicated for…

Dechra Veterinary Products has launched Osphos, an intramuscular clodronic acid injection for the control of clinical signs associated with the bone resorptive processes of navicular syndrome in horses, the only such licensed product in the UK.

Dechra…

Dechra Veterinary Products has launched Equibactin vet, a broad spectrum oral antibiotic paste that can be used to treat a wide range of infections in horses.

Equibactin vet contains sulfadiazine and trimethoprim, and is indicated for use in the treatment…

Dechra Veterinary Products has launched Tranquinervin, an injectable acepromazine for horses.

Tranquinervin, which contains 10 mg/ml acepromazine, is indicated for anaesthetic premedication, tranquilisation and sedation.

Emma Jennings, Brand Manager…

Dechra Veterinary Products has launched Rominervin, a new, fast-acting injectable solution for equine sedation and premedication.

Rominervin contains 10 mg/ml romifidine hydrochloride, equivalent to 8.76 mg romifidine, presented in a 20 ml vial.

It can be…

Dechra Veterinary Products has announced that it has acquired Dilaterol, the oral bronchodilator for horses, from the Dutch veterinary pharma company, LeVet.

Dilaterol is an oral syrup containing 25 mgs/ml clenbuterol hydrochloride, indicated to treat respiratory…

Dechra has launched Dormazolam (midazolam (5mg/ml), the first and only equine benzodiazepine licensed for the intravenous co-induction of anaesthesia in horses¹.

The company says Dormazolam works in synergy with other induction agents to provide an extended…

Dechra Veterinary Products has launched an apple-flavoured presentation of Equipalazone (phenylbutazone), its NSAID for horses and ponies. 

Equipalazone is most commonly used to treat lameness in equines and can be prescribed as a treatment for osteoarthritic…

Dechra is hosting a series of webinars about equine pain and locomotion, presented by Specialists David Bardell and Dr. Andy Fiske-Jackson.

The webinars will take place every Wednesday at 7pm in May.

David Bardell is a European and Royal College of Veterinary…

Dechra Veterinary Products has launched Strangvac, a protein-based strangles vaccine for horses and ponies.

Strangvac has been in development for over 25 years and Dechra says it's the first and only intramuscular vaccine to help protect against strangles…

Dechra Veterinary Products (maker of Strangvac) has launched a strangles toolkit to support veterinary practices wanting to talk to their clients about this disease and how to control it with vaccination.

The pack contains:

• Ready-to use social media…

Dechra is asking vets to circulate a survey about strangles to horse-owning clients.

The survey, which takes about three minutes, will assess horse owners’ experiences of strangles and includes questions on the disease including preventative measures…

Dechra is hosting webinars for vets about strangles and equine disease prevention on Tuesday 18th February and Tuesday 25th February respectively.

The webinars will be available as live podcasts and will also be able to be viewed on demand on the Dechra…

Dechra is holding ‘Preventive strategies for strangles: linking research to action’, a free one-hour webinar to help veterinary professionals translate the latest equine strangles surveillance data and research into everyday veterinary practice, at 7:00pm…

Dechra has launched Pergocoat, for the treatment of Pituitary Pars Intermedia Dysfunction (PPID), aka equine Cushing’s disease.

Pergocoat contains pergolide, a long-acting dopamine receptor agonist.

It is available in 0.5mg (off-white) and 1mg (yellow…

Dechra has launched Equisolon Jar, a new presentation of its oral prednisone powder for the treatment of severe equine asthma.

Dechra says Equisolon is the only registered oral prednisolone powder that alleviates the inflammation and clinical parameters…

Dechra has published the results of a survey which shows how vets and horse owners could do more to prevent strangles. 

The survey of 50 vets carried out in May this year¹ found that only half of them are recommending strangles vaccination to their clients…